Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14.00 | 14.96 | 12.86 | 16.44 | 18.13 | 17.35 | 18.18 | 17.89 | 15.50 | 20.86 | 10.51 | 19.46 |
| Expenses | 11.88 | 12.99 | 10.70 | 14.10 | 15.28 | 14.80 | 15.57 | 15.25 | 13.25 | 17.26 | 9.60 | 16.06 |
| Operating Profit | 2.12 | 1.97 | 2.16 | 2.34 | 2.85 | 2.55 | 2.61 | 2.64 | 2.25 | 3.60 | 0.91 | 3.40 |
| OPM % | 15.14% | 13.17% | 16.80% | 14.23% | 15.72% | 14.70% | 14.36% | 14.76% | 14.52% | 17.26% | 8.66% | 17.47% |
| Other Income | 0.15 | 0.25 | 0.05 | 0.09 | 0.39 | 0.31 | 0.43 | 0.04 | 0.16 | 0.29 | 0.75 | 0.15 |
| Interest | 0.05 | 0.08 | 0.09 | 0.02 | 0.18 | 0.19 | 0.20 | 0.22 | 0.05 | 0.21 | 0.06 | 0.18 |
| Depreciation | 0.23 | 0.24 | 0.24 | 0.13 | 0.15 | 0.16 | 0.18 | 0.16 | 0.17 | 0.19 | 0.35 | 0.31 |
| Profit before tax | 1.99 | 1.90 | 1.88 | 2.28 | 2.91 | 2.51 | 2.66 | 2.30 | 2.19 | 3.49 | 1.25 | 3.06 |
| Tax % | 14.07% | 13.16% | 33.51% | 24.56% | 21.31% | 24.30% | 17.29% | 24.78% | 25.11% | 24.93% | 25.60% | 25.16% |
| Net Profit | 1.71 | 1.65 | 1.26 | 1.71 | 2.30 | 1.90 | 2.19 | 1.73 | 1.64 | 2.62 | 0.94 | 2.30 |
| EPS in Rs | 1.71 | 1.65 | 1.08 | 1.46 | 1.97 | 1.60 | 1.84 | 1.43 | 1.34 | 2.13 | 0.77 | 1.87 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 115.31 | 32.53 | 17.96 | 25.09 | 16.29 | 25.09 | 30.59 | 41.45 | 54.41 | 70.10 | 64.76 | 66.33 |
| Expenses | 120.84 | 55.81 | 70.17 | 26.85 | 16.62 | 22.95 | 24.86 | 35.80 | 46.18 | 59.74 | 55.24 | 56.17 |
| Operating Profit | -5.53 | -23.28 | -52.21 | -1.76 | -0.33 | 2.14 | 5.73 | 5.65 | 8.23 | 10.36 | 9.52 | 10.16 |
| OPM % | -4.80% | -71.56% | -290.70% | -7.01% | -2.03% | 8.53% | 18.73% | 13.63% | 15.13% | 14.78% | 14.70% | 15.32% |
| Other Income | 0.73 | 2.85 | 0.48 | 0.96 | 0.25 | 0.26 | 0.24 | 0.54 | 0.52 | 1.21 | 1.12 | 1.35 |
| Interest | 8.81 | 4.79 | 0.45 | 0.33 | 0.66 | 0.13 | 0.21 | 0.36 | 0.25 | 0.59 | 0.54 | 0.50 |
| Depreciation | 1.36 | 1.20 | 1.19 | 1.17 | 1.07 | 0.86 | 0.88 | 0.89 | 0.93 | 0.62 | 0.86 | 1.02 |
| Profit before tax | -14.97 | -26.42 | -53.37 | -2.30 | -1.81 | 1.41 | 4.88 | 4.94 | 7.57 | 10.36 | 9.24 | 9.99 |
| Tax % | -2.20% | -0.72% | -0.60% | -10.00% | -5.52% | -0.71% | 0.61% | 8.70% | 18.63% | 21.81% | 25.00% | |
| Net Profit | -14.64 | -26.22 | -53.06 | -2.07 | -1.71 | 1.42 | 4.85 | 4.51 | 6.17 | 8.10 | 6.92 | 7.50 |
| EPS in Rs | -24.82 | -44.45 | -89.96 | -3.51 | -2.90 | 1.67 | 4.85 | 4.51 | 5.28 | 6.82 | 5.63 | 6.11 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.33% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -6% | 21% | 16% | -7% | ||
| Compounded Profit Growth | 10% | 38% | 16% | -8% | ||
| Stock Price CAGR | 27% | 45% | 17% | -25% | ||
| Return on Equity | % | % | 24% | 16% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.90 | 5.90 | 5.90 | 5.90 | 5.90 | 5.90 | 8.50 | 10.00 | 10.00 | 11.68 | 11.88 | 12.28 |
| Reserves | 26.24 | 11.60 | -14.62 | -58.72 | -53.10 | -54.81 | -53.39 | -17.58 | -13.07 | 16.22 | 26.12 | 36.10 |
| Borrowings | 57.06 | 62.20 | 59.89 | 48.23 | 48.09 | 48.91 | 46.05 | 6.00 | 2.49 | 0.97 | 5.62 | 9.16 |
| Other Liabilities | 24.48 | 13.42 | 9.15 | 29.61 | 17.09 | 15.66 | 18.11 | 19.87 | 21.59 | 14.53 | 21.37 | 20.89 |
| Total Liabilities | 113.68 | 93.12 | 60.32 | 25.02 | 17.98 | 15.66 | 19.27 | 18.29 | 21.01 | 43.40 | 64.99 | 78.43 |
| Fixed Assets | 13.52 | 12.69 | 11.19 | 10.17 | 8.99 | 8.04 | 7.62 | 7.42 | 7.57 | 9.94 | 20.56 | 22.08 |
| CWIP | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.15 |
| Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.00 | 3.00 | 4.64 |
| Other Assets | 100.10 | 80.38 | 49.08 | 14.80 | 8.94 | 7.57 | 11.60 | 10.82 | 13.39 | 33.46 | 41.43 | 50.56 |
| Total Assets | 113.68 | 93.12 | 60.32 | 25.02 | 17.98 | 15.66 | 19.27 | 18.29 | 21.01 | 43.40 | 64.99 | 78.43 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -1.20 | 0.45 | 9.57 | 3.05 | 2.48 | -0.17 | 0.58 | 8.52 | 4.68 | -10.70 | -0.24 | -1.55 |
| Cash from Investing Activity | 8.68 | -0.50 | 0.30 | -0.20 | 0.02 | -0.12 | -0.42 | -0.67 | -0.99 | -12.21 | -5.81 | -4.47 |
| Cash from Financing Activity | -7.30 | -0.51 | -10.05 | -2.83 | -2.30 | 0.33 | -0.26 | -7.68 | -3.73 | 23.16 | 6.14 | 6.54 |
| Net Cash Flow | 0.18 | -0.57 | -0.18 | 0.03 | 0.20 | 0.03 | -0.09 | 0.17 | -0.04 | 0.24 | 0.09 | 0.52 |
| Free Cash Flow | 7.47 | -0.06 | 9.87 | 2.85 | 2.50 | -0.30 | 0.15 | 7.84 | 3.63 | -14.00 | -11.48 | -5.21 |
| CFO/OP | -23% | -8% | -41% | -6% | -143% | 48% | 28% | 150% | 84% | -117% | 10% | 6% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 184.24 | 151.59 | 358.38 | 107.71 | 75.79 | 23.97 | 96.45 | 58.71 | 17.52 | 31.53 | 86.85 | 62.05 |
| Inventory Days | 68.59 | 65.35 | 127.41 | 34.08 | 13.56 | 66.80 | 22.43 | 51.89 | 105.21 | 124.70 | 93.96 | 83.05 |
| Days Payable | 37.50 | 19.51 | 42.51 | 169.13 | 292.82 | 434.62 | 261.00 | 339.20 | 269.82 | 73.56 | 137.51 | 101.33 |
| Cash Conversion Cycle | 215.34 | 197.43 | 443.28 | -27.33 | -203.47 | -343.84 | -142.12 | -228.61 | -147.08 | 82.67 | 43.30 | 43.77 |
| Working Capital Days | 61.38 | 26.72 | -196.58 | -1,285.22 | -714.43 | -1,162.44 | -707.31 | -173.01 | -129.27 | 35.55 | 83.73 | 143.38 |
| ROCE % | 5.95% | -7.31% | -35.52% | -227.18% | -258.43% | 265.52% | 55.28% | 30.21% | 19.57% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 32.34% | 32.34% | 27.67% | 27.67% | 27.67% | 27.67% | 28.87% | 28.87% | 31.20% | 31.20% | 31.26% | 31.56% |
| DIIs | 8.16% | 6.01% | 9.71% | 9.36% | 6.26% | 6.26% | 6.15% | 6.15% | 6.02% | 6.03% | 6.03% | 5.45% |
| Public | 59.51% | 61.65% | 62.62% | 62.98% | 66.08% | 66.09% | 64.97% | 64.98% | 62.77% | 62.76% | 62.71% | 62.98% |
| No. of Shareholders | 4,500 | 4,500 | 4,911 | 6,166 | 6,731 | 6,618 | 6,447 | 6,429 | 6,286 | 6,017 | 5,933 | 5,880 |
Fundamentals
Market Cap₹ 211 Cr.
Current Price₹ 172
Stock P/E28.1
Book Value₹ 39.4
ROCE19.6 %
ROE16.2 %
Dividend Yield0.29 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-7%
Compounded Profit Growth (TTM)-8%
Standalone figures.
Valuation
Market capRs 203 Cr
Enterprise valueRs 211 Cr
P/E (TTM)27.04x
Price to book4.19x
Price to sales3.06x
EV / EBITDA18.31x
EV / EBIT20.09x
EV / sales3.18x
Earnings yield3.70%
P/E, 3-year average29.05x
P/B, 3-year average5.72x
P/E, 5-year average21.97x
P/B, 5-year average-1.00x
Profitability
Operating margin (excl. other income)14.70%
Operating margin (incl. other income)16.43%
EBITDA margin17.35%
Pre-tax margin15.06%
Net profit margin11.31%
Net margin, latest quarter11.82%
ROE16.02%
ROCE19.34%
ROA9.65%
ROE, 3-year average30.10%
ROCE, 3-year average34.94%
ROA, 3-year average14.58%
ROE, 5-year average-2.58%
ROCE, 5-year average34.94%
ROA, 5-year average18.51%
ROIC (approx.)13.98%
Tax rate25.00%
Other income / net worth2.31%
Growth
Sales growth (latest year)-7.62%
Profit growth (latest year)-14.57%
Sales CAGR, 3 years16.04%
Sales CAGR, 5 years20.88%
Profit CAGR, 3 years15.34%
Profit CAGR, 5 years37.27%
Sales growth QoQ85.16%
Profit growth QoQ144.68%
Sales growth YoY (latest quarter)8.78%
Profit growth YoY (latest quarter)32.95%
Per share
EPS (TTM)Rs 6.11
EPS (latest year)Rs 5.63
EPS (latest quarter)Rs 1.87
EPS, 3-year averageRs 5.91
EPS, 5-year averageRs 5.42
Book value per shareRs 39.38
Sales per shareRs 54.00
Cash flow per shareRs -1.26
Free cash flow per shareRs -4.24
Dividend per share, 3-year averageRs 0.50
Dividend per share, 5-year averageRs 0.50
Dividends
Dividend payout, 3-year average7.28%
Dividend payout, 5-year average7.28%
Efficiency
Asset turnover0.83x
Fixed asset turnover2.93x
Inventory turnover4.70x
Inventory days78 days
Debtor days62 days
Debtors turnover5.88x
Creditor days101 days
Cash conversion cycle44 days
Working capital days143 days
Leverage
Total debtRs 9 Cr
Cash and bankRs 1 Cr
Net debtRs 8 Cr
Debt to equity0.19x
Net debt / EBITDA0.69x
Interest coverage20.98x
Owners' fund to total sources61.69%
Debt to assets11.68%
Cash flow
Cash from Operating Activity (latest year)Rs -2 Cr
Cash from Investing Activity (latest year)Rs -4 Cr
Cash from Financing Activity (latest year)Rs 7 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -5 Cr
FCFE (approx.: FCF + change in debt)Rs -2 Cr
Cash from ops / profit, 5 years0.02x
Statement figures
Net sales (TTM)Rs 66 Cr
Net sales (latest year)Rs 65 Cr
Sales (latest quarter)Rs 19 Cr
Operating profit excl. other income (latest year)Rs 10 Cr
Operating profit (latest quarter)Rs 3 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 12 Cr
PBDT (TTM)Rs 11 Cr
Profit before tax (TTM)Rs 10 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 8 Cr
Net profit (latest year)Rs 7 Cr
Net profit (latest quarter)Rs 2 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 45 Cr
Total expenditure (latest year)Rs 55 Cr
Total income (latest year)Rs 66 Cr
Share capitalRs 12 Cr
ReservesRs 36 Cr
Shareholders' fundsRs 48 Cr
Total assetsRs 78 Cr
Net blockRs 22 Cr
Capital work in progressRs 1 Cr
InvestmentsRs 5 Cr
ReceivablesRs 11 Cr
InventoryRs 10 Cr
Other liabilitiesRs 21 Cr
Shares outstanding (crore)1.23
Ownership
Promoter holding31.56% (+2.69 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 27.0 is at the 37th percentile of its own 5.4-year range
(median 31.5, low 8.6, high 71.7).
P/B 4.19 is at the 7th percentile (median 7.40).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 531569 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.9% | -2.8% | -1.1 pts |
| 1 month | -10.3% | -6.8% | -3.5 pts |
| 3 months | +6.7% | -7.6% | +14.3 pts |
| 3 years | +53.2% | +14.2% | +39.1 pts |
| 5 years | +502.6% | +27.9% | +474.7 pts |
Red flags
F-score 1 of 8| explain | Weak cash conversion Cash from operations was -59% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 11% of total assets in 2026 |
| explain | Debt up, profit down Borrowings up 63% while net profit fell in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹19 Cr +8.8% vs Jun 2025.
Net profit ₹2 Cr +32.9%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Sanjivani Paranteral Ltd?
Sanjivani Paranteral Ltd (531569) has a market capitalisation of Rs 211 Cr. at the 2026-10-01 close.
What is the P/E ratio of Sanjivani Paranteral Ltd?
Sanjivani Paranteral Ltd trades at a P/E of 28.1 on trailing twelve-month profit, at the 2026-10-01 close.
What were Sanjivani Paranteral Ltd's latest quarterly results?
In the Jun 2026 quarter, Sanjivani Paranteral Ltd sales was Rs 19 Cr (+8.8% vs Jun 2025) and net profit was Rs 2 Cr.